.

Def Leppard and Journey Tour Rocked Over 1 Million Fans 2018 In Review


01-04-2019
Def Leppard

(hennemusic) Def Leppard and Journey Tour Rocked Over 1 Million Fans was a top 18 story of October 2018: The recently-completed co-headlining tour of North America by rock heavyweights Def Leppard and Journey played to more than 1 million fans on the continent.

Billboard reports the extensive six-month, 58-date series sold 1,003,198 tickets to earn a total box office revenue of $97.1 million. The biggest single-show revenue was the fourth and final leg's opener - a September 21 stop at AT&T Park in San Francisco, CA - which grossed $3.9 million.

The biggest venue on the run's 10-show stadium series was a June 1 gig at Toronto's Rogers Centre, with 45,083 tickets available for sale. Def Leppard and Journey wrapped up the North American run with a two-night engagement at the Forum in Inglewood, CA on October 6-7.

The groups' previous joint tour in 2006 took in gross revenue of $38 million over 72 dates. Read more here.

hennemusic is an official news provider for antiMusic.com.
Copyright hennemusic - Excerpted here with permission.


Related Stories


iHeartRadioMusic Festival Add More Stars To Lineup

Last In Line To Begin Work On Album During Def Leppard Break

Def Leppard Already Working On Next Album

Guns N' Roses, Def Leppard Lead Music Festival Lineups

Joe Elliott Jams Def Leppard Classic With Billy Joel

Def Leppard Star On Van Halen Vs. Van Hagar

Def Leppard Stream Rock Hall Speech, Behind The Scenes Video

Def Leppard Announce Next Box Set Series Release

Guns N' Roses, Def Leppard, Megadeth Lead New Festival Lineup

Def Leppard Rock Hall Induction TV Special Preview Released

More Def Leppard News

Share this article

Share on Facebook Share on Twitter Share on Google+ Pin it Share on Reddit email this article



advertisement




Day In Rock Reports


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2019 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.